Here’s what you should know.
1. Takeda and NuBiyota are collaborating on oral microbial consortia products, which NuBiyota will develop.
2. Takeda will pay NuBiyota an upfront payment as well as several developmental, regulatory, commercial and sales-based incentives.
3. Takeda recently entered into a similar agreement with Finch Therapeutics over its inflammatory bowel disease treatment.
More articles on gastroenterology:
Adrienne Wilson Liver Cancer Association awards Dr. Amit Singal the Blue Faery Award: 4 insights
GI leader to know: Dr. Seth Gross of NYU Langone Medical Center
Pfizer awards Dr. Declan McCole $150k grant for IBD research: 4 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
